GATA3 and breast carcinoma: MCF-7 harbors the GATA3 frameshift mutation p.D335Gfs23, a truncating mutation recurrently observed in breast cancer patients1,4 and that has been reported to have both loss and gain-of-function effects, and specifically acts as a dominant-negative mutant with lower DNA binding affinity but increased half-life24.